- Clear Secure announced that its CLEAR1 identity verification platform is now integrated into Epic Toolbox for EpicCare Link and electronic prescribing of controlled substances, supported by DEA compliant certifications and recent quarterly results that reported US$292.85 million in Q3 2026 sales and US$53.17 million in net income.
- The combination of high assurance healthcare integrations, a consumer facing partnership with goop kitchen, and management’s Q4 2026 revenue outlook of US$299 million to US$302 million highlights how Clear Secure is expanding its identity platform beyond airport lanes into both clinical workflows and everyday customer touchpoints.
- This article will examine how Clear Secure's investment narrative intersects with CLEAR1's Epic healthcare integrations and consider what that may imply for investors.
Compare Clear Secure’s expanding identity platform with a curated group of peers that are shaping secure digital workflows and clinical verification by scanning our 30 resilient stocks with low risk scores, which is aligned with resilient balance sheets and lower risk profiles.
Clear Secure Investment Narrative Recap
To own Clear Secure, you need to believe its identity platform can keep scaling beyond airport lanes into areas like healthcare, government and everyday consumer use. The analyst consensus Narrative on Simply Wall St hinges on identity becoming critical infrastructure. The new Epic integrations speak directly to that idea, since they put CLEAR1 into high assurance clinical workflows that value security and compliance.
In the near term, execution on this broader roll out still looks like the key catalyst. Membership seasonality and leadership transition remain live risks. The Epic launch does not change those issues, but it does slightly reduce concentration in airport traffic by adding another regulated, high stakes use case.
The Epic Toolbox integrations look most relevant because they tie directly to the CLEAR1 B2B catalyst that analysts flag as a driver of future contract wins and subscription style revenue. CLEAR1 is now live for EpicCare Link and electronic prescribing of controlled substances, backed by DEA compliant Drummond certification under 21 CFR Part 1311.
For you as a shareholder, that matters less as a press release and more as proof that Clear Secure can meet strict identity, authentication and audit trail standards in healthcare. Successful execution here can help diversify revenue away from airport memberships. However, it also raises the bar on uptime, compliance risk management and support costs across a more complex enterprise customer base.
Clear Secure's narrative projects US$1.6b revenue and US$341.5 million earnings by 2029. This aligns with analysts who are factoring in 13.8% yearly revenue growth and an earnings increase of about US$168.7 million from US$172.8 million today.
Uncover why Clear Secure's fair value indicates a 20% potential upside to its current price before the discount gap closes.
Exploring Other Perspectives
One bearish thread around Clear Secure focuses on rising compliance and security costs. The lowest analysts were already penciling in earnings of about US$326.0 million by 2029 on 13.5% yearly revenue growth, below the consensus path. The new Epic healthcare integrations could push those expectations up or down, which is why it is important to explore several viewpoints.
Explore 3 other Clear Secure fair value estimates, including one that suggests it could be worth just $66.33.
The Verdict Is Yours
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
- A great starting point for your Clear Secure research is our analysis highlighting 2 key rewards that could impact your investment decision.
- See our latest analysis for Clear Secure. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Clear Secure's overall financial health at a glance.
Looking for more investment ideas beyond Clear Secure?
If Clear Secure has sharpened your thinking around identity, security and durable cash flows, it can be useful to line that story up against other opportunities with different risk and income profiles.
- If capital preservation sits high on your list, compare Clear Secure's risk profile with a 30 resilient stocks with low risk scores that focuses on resilience and steadier fundamentals.
- For readers aiming to balance quality with entry price, scan a 32 high quality undervalued stocks that screens for stocks where fundamentals and market expectations are out of sync.
- If income is a core part of your plan, weigh Clear Secure against a 6 dividend fortresses that concentrates on yields from companies with stronger payout potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com